tm
Seeing Is Believing
tm
Seeing Is Believing
CARA is currently covered by 4 analysts with an average potential upside of $9.97 (101.24%) backed by displayed 33 price targets and 42 ratings.
Analysts average stock forecasts to be materialized ratio is 43.81% with an average time for these price targets to be met of 259.91 days.
Highest price target for CARA is 12, Lowest price target is 1, average price target is 6.5.
Most recent stock forecast was given by DAVID AMSELLEM from PIPER SANDLER on 14-Nov-2023. First documented stock forecast 27-Feb-2014.
Currently, out of the existing stock ratings of CARA - 2 which are a Hold (20%), 6 which are a Buy (60%), 2 which are a Sell (20%)
Analyst name
Rating
Current price target
Potential distance
Previous price target
Date
Price targets met ratio
Average potential upside
Average time for PT to be met
Performance score
Buy
1
$0.02 (2.04%)
16 days ago
1/6 (16.67%)
$9.87 (59.16%)
8
Buy
25
3 months 21 days ago
0/1 (0%)
$18.31 (273.69%)
Sell
3.5
$2.52 (257.14%)
4
3 months 21 days ago
2/4 (50%)
$2.54 (31.28%)
30
Buy
22
$20.32 (1209.52%)
22
3 months 22 days ago
0/6 (0%)
$16.06 (310.35%)
Buy
3 months 22 days ago
2/5 (40%)
$10.41 (56.32%)
234
What is CARA (Cara Therapeutics) average time for price targets to be met?
Which analyst has the current highest performing score on CARA (Cara Therapeutics) with a proven track record?
Which analyst has the most public recommendations on CARA (Cara Therapeutics)?
Which analyst is the currently most bullish on CARA (Cara Therapeutics)?
Which analyst is the currently most reserved on CARA (Cara Therapeutics)?
